For more than 15 years, shortages of critical drugs — from oncology treatments to emergency room and surgical suite essentials — have burdened healthcare systems and compromised patient car
About 150 prescription drugs, including antibiotics, generics and some branded drugs without alternatives, could be at risk of shortage if the COVID-19 coronavirus outbreak worsens accordin
Roche’s treatment for Huntington’s disease has received a priority designation by the European regulator, sparking hope that a cure may be in the pipeline.
The government must prioritise remaining a member of the European Medicines Agency in Brexit negotiations, after a key Parliamentary vote where it fought off moves to keep it tied to the cu
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh